By Dr Sukriti Krishan

Journal articles

Krishan S; Koach J; Lim T; Yeo K; Cheong F; Luo JS; Massudi H; Gao X; Heangsarath S; Kueh AJ; Herold MJ; Cheung BB; Marshall GM, 2025, 'PA2G4 Functions as a Cofactor for MYC Family Oncoproteins in MYC-Driven Malignancies', Cells, 14, http://dx.doi.org/10.3390/cells14181422

Seneviratne JA; Ravindrarajah D; Carter DR; Zhai V; Lalwani A; Krishan S; Balachandran A; Ng E; Pandher R; Wong M; Nero TL; Wang S; Norris MD; Haber M; Liu T; Parker MW; Cheung BB; Marshall GM, 2024, 'Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma', Cancer Medicine, 13, pp. e70082, http://dx.doi.org/10.1002/cam4.70082

Ravindrarajah D; Krishan S; Simpson K; Gulati T; Cheung BB; Marshall GM, 2024, 'Abstract 1080: Using genome-wide CRISPR screening to develop novel combination therapies for high-risk Ewing’s sarcoma', Cancer Research, 84, pp. 1080 - 1080, http://dx.doi.org/10.1158/1538-7445.am2024-1080

Massudi H; Luo JS; Holien JK; Gadde S; Krishan S; Herath M; Koach J; Stevenson BW; Gorman MA; Venkat P; Mayoh C; Luo XQ; Parker MW; Cheung BB; Marshall GM, 2023, 'Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface', Cancers, 15, http://dx.doi.org/10.3390/cancers15061822

Krishan S; Sahni S; Richardson DR, 2020, 'The anti-tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-mTORC1 axis', Biochimica Et Biophysica Acta Molecular Basis of Disease, 1866, http://dx.doi.org/10.1016/j.bbadis.2020.165970

Krishan S; Sahni S; Leck LYW; Jansson PJ; Richardson DR, 2020, 'Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells', Biochimica Et Biophysica Acta Molecular Basis of Disease, 1866, http://dx.doi.org/10.1016/j.bbadis.2019.165657

Krishan S; Richardson DR; Sahni S, 2016, 'The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells', Biochimica Et Biophysica Acta Molecular Cell Research, 1863, pp. 2916 - 2933, http://dx.doi.org/10.1016/j.bbamcr.2016.09.011

Sahni S; Kovacevic Z; Kalinowski DS; Huang M; Menezes S; Krishan S; Lane DJ; Jansson PJ; Richardson DR, 2016, 'Targeting autophagy in antitumor agent design: Furthering the 'lysosomal love' strategy', Future Medicinal Chemistry, 8, pp. 727 - 729, http://dx.doi.org/10.4155/fmc-2016-0066

Krishan S; Richardson DR; Sahni S, 2015, 'Adenosine monophosphate -activated kinase and its key role in catabolism: Structure, regulation, biological activity, and pharmacological activation', Molecular Pharmacology, 87, pp. 363 - 377, http://dx.doi.org/10.1124/mol.114.095810

Sahni S; Krishan S; Palanimuthu D; Richardson DR, 2015, 'The use of iron chelators in biocidal compositions: Evaluation of patent, WO2014059417A1', Expert Opinion on Therapeutic Patents, 25, pp. 367 - 372, http://dx.doi.org/10.1517/13543776.2014.989215

Krishan S; Jansson PJ; Gutierrez E; Lane DJR; Richardson D; Sahni S, 2015, 'Iron metabolism and autophagy: A poorly explored relationship that has important consequences for health and disease', Nagoya Journal of Medical Science, 77, pp. 1 - 6

Krishan S; Richardson DR; Sahni S, 2014, 'AMP kinase (PRKAA1)', Journal of Clinical Pathology, 67, pp. 758 - 763, http://dx.doi.org/10.1136/jclinpath-2014-202422

Sahni S; Merlot AM; Krishan S; Jansson PJ; Richardson DR, 2014, 'Gene of the month: BECN1', Journal of Clinical Pathology, 67, pp. 656 - 660, http://dx.doi.org/10.1136/jclinpath-2014-202356

Sahni S; Krishan S; Richardson DR, 2014, 'NDRG1 as a molecular target to inhibit the epithelial-mesenchymal transition: The case for developing inhibitors of metastasis', Future Medicinal Chemistry, 6, pp. 1241 - 1244, http://dx.doi.org/10.4155/fmc.14.80

Conference Papers

Krishan S; Sahni S; Richardson DR, 2018, 'The anticancer agent Dp44mT upregulates the AMPK-dependent energy homeostasis pathway in cancer cells', in MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1535-7163.TARG-17-B142

Back to profile page